Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 1
1983 2
1984 4
1985 5
1986 2
1987 4
1988 9
1989 5
1990 3
1991 3
1992 9
1993 6
1994 9
1995 11
1996 6
1997 8
1998 7
1999 7
2000 10
2001 15
2002 15
2003 27
2004 29
2005 43
2006 58
2007 40
2008 66
2009 83
2010 93
2011 99
2012 113
2013 151
2014 147
2015 187
2016 179
2017 204
2018 244
2019 270
2020 306
2021 351
2022 405
2023 347
2024 365
2025 462
2026 183

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,102 results

Results by year

Filters applied: . Clear all
Page 1
Treg-microglia partnership in the injured spinal cord preserves Treg cell function and regulates microglial cholesterol metabolism.
Qin T, Jiang T, Zhou Z, Wu M, Zhang Y, Yang Z, Zheng Z, Yi J, Wang X, Luo M, Gao P, Liu J, Huang Y, Liu H, Li Q, Zhou W, Zhang S, Guo X, He B, Wang Y, Fan J, Zhao S, Chen J, Yin G. Qin T, et al. Among authors: yin g. Neuron. 2025 Dec 3;113(23):3983-4000.e7. doi: 10.1016/j.neuron.2025.09.001. Epub 2025 Sep 29. Neuron. 2025. PMID: 41027425
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204).
Jin ZC, Wei J, Xiao YD, Si A, Chen JJ, Zhu XL, Li JZ, Nie F, Ding R, Zhou HF, Ding W, Zhong BY, Xie Y, Hu HT, Yin GW, Ji JS, Zhang WH, Shi HB, Wu JB, Xu GH, Yuan CW, Yang WZ, Liu RB, Wu YM, Zheng CS, Xu AB, Huang MS, Li JP, Chen L, Wen SW, Wang YQ, Gu SZ, Li D, Wang D, Zhou GH, Wang WD, Peng Z, Wang X, Zhu HD, Tian J, Teng GJ. Jin ZC, et al. Among authors: yin gw. Hepatology. 2025 Nov 10. doi: 10.1097/HEP.0000000000001593. Online ahead of print. Hepatology. 2025. PMID: 41213031
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial.
Zhou J, Bai L, Luo J, Bai Y, Pan Y, Yang X, Gao Y, Shi R, Zhang W, Zheng J, Hua X, Xu A, Hu S, Zhang F, Yang X, Da M, Wang R, Ma J, Jia W, Quan D, Peng C, Yang W, Yin G, Qi Y, Zhang G, Du X, Mao X, Meng Z, Jiao S, Fan J; APOLLO Study Group. Zhou J, et al. Among authors: yin g. Lancet Oncol. 2025 Jun;26(6):719-731. doi: 10.1016/S1470-2045(25)00190-1. Epub 2025 May 8. Lancet Oncol. 2025. PMID: 40349716 Clinical Trial.
4,102 results